Lv1
20 积分 2024-11-18 加入
Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues
8天前
已完结
Preclinical development and a case report of a nanobody-based CLDN18.2 CAR-T IMC002 with reduced on-target off-tumor toxicity
3个月前
已完结
Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues
4个月前
已完结
Nanobody-based naturally selected CD7-targeted CAR-T therapy for acute myeloid leukemia
4个月前
已完结
Characteristics of anti-CLL1 based CAR-T therapy for children with relapsed or refractory acute myeloid leukemia: the multi-center efficacy and safety interim analysis
4个月前
已完结
Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction
5个月前
已完结
AI-driven protein design
6个月前
已完结
Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders
6个月前
已完结
Macrophages as regulators of tumour immunity and immunotherapy
7个月前
已完结
Linking macrophage metabolism to function in the tumor microenvironment
7个月前
已完结
皖公网安备34019202002308
